Holen Sie sich die Stockscreener-App
19.44
1.72%
-0.34
Finanzdaten der Urogen Pharma Ltd-Aktie (URGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
19.56%
24.21
|
20.25 | 24.57 | 25.20 | 21.85 |
| Cost Of Revenue |
52.36%
3.55
|
2.33 | 2.471 | 2.453 | 2.229 |
| Gross Profit |
15.29%
20.66
|
17.92 | 22.09 | 22.75 | 19.62 |
Operating Expenses
|
13.27%
62.11
|
54.84 | 49.75 | 40.30 | 45.46 |
| Benefits Costs and Expenses |
14.81%
73.14
|
63.70 | - | - | - |
| Costs And Expenses |
14.81%
73.14
|
63.70 | - | - | - |
| Operating Income/Loss |
12.28%
-41.45
|
-36.91 | -27.66 | -17.55 | -25.84 |
| Nonoperating Income/Loss |
320.00%
-0.378
|
-0.09 | -0.062 | -0.158 | -0.014 |
| Income/Loss From Continuing Operations Before Tax |
12.60%
-48.92
|
-43.45 | 24.57 | -23.58 | -33.37 |
| Income Tax Expense/Benefit |
158.93%
1.015
|
0.392 | 2.649 | 0.091 | 0.038 |
| Income/Loss From Continuing Operations After Tax |
13.91%
-49.94
|
-43.84 | -37.51 | -23.67 | -33.40 |
|
Net Income/Loss
|
13.91%
-49.94
|
-43.84 | -37.51 | -23.67 | -33.40 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.67%
47.74
|
47.42 | 47.03 | 46.78 | 40.50 |
| Basic Earnings Per Share |
14.13%
-1.05
|
-0.92 | -0.80 | -0.51 | -0.82 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.94%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):